Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome

European Journal of Internal Medicine

Volumn 25, Issue 5, 2014, Pages 471-476

  Kanbay, Asiye ^a   Inonu, Handan ^b   Solak, Yalcin ^c   Erden, Abdulsamet ^d   Uslu, Emine ^d   Yuksel, Sevgi Arik ^d   Ozturk, Mehmet Akif ^a   McFann, Kim ^e   Johnson, Richard J ^e   Kanbay, Mehmet ^a  

^a ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

^c Karaman State Hospital   (Turkey)

^d Department of Medicine Kayseri Training and Research Hospital ^*  (Turkey)

^e Department of Mathematical and Statistical Sciences   (United States)

Author keywords

Cardiovascular disease; Cardiovascular risk factor; Obstructive sleep apnea; Uric acid

Indexed keywords

URIC ACID;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORBIDITY; SLEEP DISORDERED BREATHING; URIC ACID BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASES; HYPERURICEMIA; RISK FACTOR; SLEEP APNEA, OBSTRUCTIVE;

CARDIOVASCULAR DISEASES; COHORT STUDIES; HUMANS; HYPERURICEMIA; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; URIC ACID;

EID: 84901588642     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.04.005     Document Type: Article

References (28)

1. J.M. Parish, and V.K. Somers Obstructive sleep apnea and cardiovascular disease Mayo Clin Proc 79 2004 1036 1046
2. S. Sharma, M. Gebregziabher, A.T. Parker, J.A. Abro, A.M. Armstrong, and U.J. Schoepf Independent association between obstructive sleep apnea and noncalcified coronary plaque demonstrated by noninvasive coronary computed tomography angiography Clin Cardiol 35 2012 641 645
3. A. Lurie Cardiovascular disorders associated with obstructive sleep apnea Adv Cardiol 46 2011 197 266
4. A. Ozkok, A. Kanbay, A.R. Odabas, A. Covic, and M. Kanbay Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor Clin Exp Hypertens 2014 Jan 16 [Epub ahead of print]
5. M. Kanbay, Y. Solak, E. Dogan, M.A. Lanaspa, and A. Covic Uric acid in hypertension and renal disease: the chicken or the egg? Blood Purif 30 2010 288 295
6. M. Kanbay, M. Segal, B. Afsar, D.H. Kang, B. Rodriguez-Iturbe, and R.J. Johnson The role of uric acid in the pathogenesis of human cardiovascular disease Heart 99 2013 759 766
7. M. Kanbay, M.I. Yilmaz, A. Sonmez, Y. Solak, M. Saglam, and E. Cakir et al. Serum uric acid independently predicts cardiovascular events in advanced nephropathy Am J Nephrol 36 2012 324 331
8. S.D. Navaneethan, and S. Beddhu Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease Nephrol Dial Transplant 24 2009 1260 1266
9. A. Dutta, W. Henley, L.C. Pilling, R.B. Wallace, and D. Melzer Uric acid measurement improves prediction of cardiovascular mortality in later life J Am Geriatr Soc 61 2013 319 326
10. L.F. Drager, H.F. Lopes, C. Maki-Nunes, I.C. Trombetta, E. Toschi-Dias, and M.J. Alves et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome PLoS One 5 2010 e12065
11. S.L. Verhulst, K. Van Hoeck, N. Schrauwen, D. Haentjens, R. Rooman, and L. Van Gaal et al. Sleep-disordered breathing and uric acid in overweight and obese children and adolescents Chest 132 2007 76 80
12. P. Steiropoulos, I. Kotsianidis, E. Nena, V. Tsara, E. Gounari, and O. Hatzizisi et al. Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome Sleep 32 2009 537 543
13. K. Van Hoorenbeeck, H. Franckx, P. Debode, P. Aerts, K. Wouters, and J. Ramet et al. Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid Obesity (Silver Spring) 20 2012 172 177
14. D. Martinez, C. Klein, L. Rahmeier, R.P. da Silva, C.Z. Fiori, and C.M. Cassol et al. Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors Sleep Breath 16 2012 695 701
15. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension J Hypertens 25 2007 1751 1762
16. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association Sleep 15 1992 173 184
17. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force Sleep 22 1999 667 689
18. M.W. Johns A new method for measuring daytime sleepiness: the Epworth sleepiness scale Sleep 14 1991 540 545
19. L. Lavie, A. Hefetz, R. Luboshitzky, and P. Lavie Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment J Mol Neurosci 21 2003 57 63
20. F.J. Nieto, T.B. Young, B.K. Lind, E. Shahar, J.M. Samet, and S. Redline et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study JAMA 283 2000 1829 1836
21. M.R. Mannarino, F. Di Filippo, and M. Pirro Obstructive sleep apnea syndrome Eur J Intern Med 23 2012 586 593
22. H. Greenberg, X. Ye, D. Wilson, A.K. Htoo, T. Hendersen, and S.F. Liu Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo Biochem Biophys Res Commun 343 2006 591 596
23. E.C. Fletcher, J. Lesske, W. Qian, C.C. Miller III, and T. Unger Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats Hypertension 19 1992 555 561
24. M. Kanbay, B. Afsar, and A. Covic Uric acid as a cardiometabolic risk factor: to be or not to be Contrib Nephrol 171 2011 62 67
25. R.J. Johnson, L.G. Sanchez-Lozada, M. Mazzali, D.I. Feig, M. Kanbay, and Y.Y. Sautin What are the key arguments against uric acid as a true risk factor for hypertension? Hypertension 61 2013 948 951
26. S.Y. Kim, J.P. Guevara, K.M. Kim, H.K. Choi, D.F. Heitjan, and D.A. Albert Hyperuricemia and coronary heart disease: a systematic review and meta-analysis Arthritis Care Res (Hoboken) 62 2010 170 180
27. M. Kanbay, M. Ikizek, Y. Solak, Y. Selcoki, S. Uysal, and F. Armutcu et al. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease Am J Nephrol 33 2011 325 331
28. L. Lavie, and V. Polotsky Cardiovascular aspects in obstructive sleep apnea syndrome - molecular issues, hypoxia and cytokine profiles Respiration 78 2009 361 370